Active substance |
Cemiplimab |
Holder |
Sanofi |
Status |
Closed |
Indication |
Treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation. |
Public documents |
|
Last update |
01/04/2021 |
Libtayo
Last updated on 10/09/2024